3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma
2569
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2084
Lymphoma, Non-Hodgkin
2055
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Lymphoma, Follicular
1651
Lymphoma, Large B-Cell, Diffuse
1596
Leukemia
1170
Hodgkin Disease
1127
Lymphoma, Mantle-Cell
1110
Burkitt Lymphoma
887
Leukemia, Myeloid, Acute
884
Lymphoma, B-Cell, Marginal Zone
788
Recurrence
777
Multiple Myeloma
744
Lymphoma, B-Cell
702
Myelodysplastic Syndromes
614
Neoplasms
492
Lymphoma, T-Cell, Cutaneous
479
Waldenstrom Macroglobulinemia
470
Lymphoma, Large-Cell, Immunoblastic
456
Mycosis Fungoides
383
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
382
Lymphoma, Large-Cell, Anaplastic
362
Sezary Syndrome
321
Lymphoma, T-Cell, Peripheral
320
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
307
Hematologic Neoplasms
298
Myeloproliferative Disorders
288
Neoplasms, Plasma Cell
270
Blast Crisis
261
Interventions
salicylhydroxamic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Substance Withdrawal Syndrome
×
Lymphoid
×
Clear all
NCT04850664
2021-08-06
CBOT-OUD
Evon Medics LLC
Phase 2
Unknown
190 enrolled